Metabolic reprogramming:a new option for the treatment of spinal cord injury

扫码查看

原文链接

万方数据

外文摘要：Spinal cord injuries impose a notably economic burden on society,mainly because of the severe after-effects they cause.Despite the ongoing development of various therapies for spinal cord injuries,their effectiveness remains unsatisfactory.However,a deeper understanding of metabolism has opened up a new therapeutic opportunity in the form of metabolic reprogramming.In this review,we explore the metabolic changes that occur during spinal cord injuries,their consequences,and the therapeutic tools available for metabolic reprogramming.Normal spinal cord metabolism is characterized by independent cellular metabolism and intercellular metabolic coupling.However,spinal cord injury results in metabolic disorders that include disturbances in glucose metabolism,lipid metabolism,and mitochondrial dysfunction.These metabolic disturbances lead to corresponding pathological changes,including the failure of axonal regeneration,the accumulation of scarring,and the activation of microglia.To rescue spinal cord injury at the metabolic level,potential metabolic reprogramming approaches have emerged,including replenishing metabolic substrates,reconstituting metabolic couplings,and targeting mitochondrial therapies to alter cell fate.The available evidence suggests that metabolic reprogramming holds great promise as a next-generation approach for the treatment of spinal cord injury.To further advance the metabolic treatment of the spinal cord injury,future efforts should focus on a deeper understanding of neurometabolism,the development of more advanced metabolomics technologies,and the design of highly effective metabolic interventions.

外文关键词：

axonsglycolysismetabolic reprogrammingmetabolismmitochondrianeural regenerationneuroprotectionoxidative phosphorylationspinal cord injurytherapy

作者：

Jiangjie Chen、Jinyang Chen、Chao Yu、Kaishun Xia、Biao Yang、Ronghao Wang、Yi Li、Kesi Shi、Yuang Zhang、Haibin Xu、Xuesong Zhang、Jingkai Wang、Qixin Chen、Chengzhen Liang

展开 >

作者单位：

Department of Orthopedics,The Second Affiliated Hospital of Zhejiang University School of Medicine,Hangzhou,Zhejiang Province,China

Orthopedics Research Institute of Zhejiang University,Zhejiang University,Hangzhou,Zhejiang Province,China

Key Laboratory of Motor System Disease Research and Precision Therapy of Zhejiang Province,Hangzhou,Zhejiang Province,China

Clinical Research Center of Motor System Disease of Zhejiang Province,Hangzhou,Zhejiang Province,China

Qiandongnan Prefecture People's Hospital,Kaili,Guizhou Province,China

Department of Orthopedics,Fourth Medical Center,Chinese PLA General Hospital,Beijing,China

展开 >

出版年：

2025

DOI：

10.4103/NRR.NRR-D-23-01604

中国神经再生研究(英文版)

中国康复医学会

中国神经再生研究(英文版)

影响因子：0.902

ISSN：1673-5374

年,卷(期)：2025.20(4)